Indication | Decreased cardiac function with risk of arrhythmia |
Dose | 6 to 12 mcg/kg loading dose over 30 min followed by 0.1 mcg/kg/min for 6 h and then increase to 0.2 mcg/kg/min if tolerated |
Precautions | Reduce milrinone dose if used concomitantly |
Contraindications | Asphyxia due to potential altered affects in the pulmonary vasculature following asphyxia |
Class of Recommendation | Class IIb – Usefulness/efficacy is less well established by evidence/opinion. May be considered |
Level of Evidence | C – Consensus of opinion of the experts and/or small studies, retrospective studies, registries |